TB community requests WHO to put micobacterium tuberculosis on the Global Priority List of antibiotic-resistant bacteria
- 08.03.2017 02:44
- Post Views: 573
Below you will find the letter, prepared by Stop TB Partnership. If you wish to add your signature to the petition, please send your name and name of your organization to Colleen Daniels (email@example.com).
2 March 2017
Global TB community demands inclusion of mycobacterium tuberculosis in the WHO’s Global Priority List of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics.
Dear Dr Chan, Dr Ren, Dr Kieny and Dr Inoue,
We are writing to you collectively as the representatives of the global TB community to express our deepest concerns about the exclusion of Mycobacterium tuberculosis within WHO’s first-ever ‘global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics’, published on 27 February 2017.
While the list is a great initiative to guide us towards a world without resistance to antibiotics, it is outrageous that Mycobacterium tuberculosis was left out of consideration, for the reason that ‘it is already a globally established priority’. In other words, TB was not considered for inclusion in a global priority list, because it is evidently a global priority. This explanation defies reason.
TB’s exclusion sends the false and counterproductive message that drug-resistant TB is not a public health threat. As we are well aware, TB is the world’s leading infectious disease killer and drug-resistant TB is responsible for one-third of all AMR deaths. It also provides the wrong impression that funding for TB R&D has been secured, though we know that the TB R&D funding available represents barely 30% of the needs and has been declining for the least three years.
Dr. Chan, we acknowledge and thank you for the statement on 28 February in which you clearly highlighted that “Addressing drug-resistant TB research is a top priority for WHO and for the world”.
However, we, the undersigned individuals and organizations, demand that you show strong leadership by facilitating the timely review of the Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics in order to includemycobacterium tuberculosis on it.
This review should be conducted without any further delay to include its findings within the ‘full protocol and results’ to be published on the WHO website no later than end of May 2017.
Regional Civil Society Meeting “Ensuring meaningful community engagement during the development of national funding requests for Global Fund Grant Cycle 7 (GC7) in EECA in 2023”Post Views: 7 Read more
Key Outcomes from the 49th Global Fund Board MeetingСommunique on the Key Outcomes from the 49th Global Fund Board Meeting which took place on 10 – 11 of May in Hanoi, Vietnam, issued by the Developing Country NGO (DCNGO) Delegation to the Global Fund Board. Post Views: 13 Read more
Services for migrants and refugees from Ukraine – HIV/TB care with a focus on key populations
Due to the increasing flows of refugees from Ukraine because of Russia’s invasion of Ukraine, the EECA Regional Platform created a spreadsheet to fill contacts details of face-to-face and online services for refugees and migrants (with a focus on HIV/TB care and key population groups).
If you provide such services or know verified providers, please fill out the spreadsheet at your earliest convenience, and, please, update it as more verified information is available. These can be services for national citizens if they are also accessible to international migrants and refugees.
Regional Platform – EECA
This web-resource is a part of new regional communication and coordination project “Regional Civil Society and Community Support, Coordination and Communication Platform - EECA”, implemented by Eurasian Harm Reduction Association (EHRA).
The worsening HIV crisis in Eastern Europe and Central Asia 31.05.2023 14:36
Key Outcomes from the 49th Global Fund Board Meeting 30.05.2023 10:39
Webinar: Updates on C19RM and Pandemic Preparedness 29.05.2023 11:11